Drug Shortage Report for PROLENSA
Report ID | 43053 |
Drug Identification Number | 02439123 |
Brand name | PROLENSA |
Common or Proper name | PROLENSA |
Company Name | BAUSCH & LOMB INC |
Market Status | MARKETED |
Active Ingredient(s) | Bromfenac |
Strength(s) | 0.07% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 3ML |
ATC code | S01BC |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-05-10 |
Estimated end date | |
Actual end date | 2018-06-15 |
Shortage status | Resolved |
Updated date | 2018-06-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-06-20 | French | Compare |
v9 | 2018-06-20 | English | Compare |
v8 | 2018-05-11 | French | Compare |
v7 | 2018-05-11 | English | Compare |
v6 | 2018-05-04 | French | Compare |
v5 | 2018-05-04 | English | Compare |
v4 | 2018-04-19 | French | Compare |
v3 | 2018-04-19 | English | Compare |
v2 | 2018-03-16 | French | Compare |
v1 | 2018-03-16 | English | Compare |
Showing 1 to 10 of 10